Skip to main content

Decode the Science of Peptides. No Vendors. No Hype.

Evidence-graded profiles for 40+ peptides. Side-by-side comparisons, FDA status tracking, dosing protocols, and safety data — all independent, all free.

Trending Peptides in 2026

The most searched and studied peptides right now, ranked by evidence quality.

Head-to-Head Comparisons

Side-by-side breakdowns of the most commonly compared peptides.

FDA-Approved Peptides

These peptides have the highest level of clinical evidence and are approved by the FDA for specific indications.

Semaglutide

FDA ✓

FDA-approved for weight management and type 2 diabetes

A GLP-1 receptor agonist and the gold standard for evidence-based weight loss peptide therapy. Demonstrated 14.9–16.9% mean body weight reduction in the landmark STEP trials.

Tirzepatide

FDA ✓

FDA-approved for weight management and type 2 diabetes

A dual GIP/GLP-1 receptor agonist that achieved up to 22.5% mean weight loss in the SURMOUNT-1 trial — the highest of any FDA-approved weight loss medication.

PT-141

FDA ✓

FDA-approved for hypoactive sexual desire disorder (HSDD) in women

A melanocortin receptor agonist that works directly on the nervous system to increase sexual desire. The only FDA-approved peptide for sexual dysfunction that acts on the brain rather than vascular system.

Tesamorelin

FDA ✓

FDA-approved for HIV-associated lipodystrophy

An FDA-approved GHRH analog that stimulates natural growth hormone production. Clinically proven to reduce visceral adipose tissue and increasingly used off-label for body recomposition.

Sermorelin

FDA ✓

FDA-approved (1990) for pediatric growth hormone deficiency; off-label adult use via compounding pharmacies

The original synthetic GHRH(1–29) and the most accessible GH-stimulating peptide for age-related hormone decline. Stimulates the body's own pulsatile GH release rather than replacing it.

Liraglutide

FDA ✓

FDA-approved for weight management (Saxenda) and type 2 diabetes (Victoza)

The original once-daily GLP-1 receptor agonist. Lower weight-loss magnitude than semaglutide but a longer real-world track record across diabetes and obesity.

Afamelanotide

FDA ✓

FDA-approved (2019) for erythropoietic protoporphyria (EPP)

An FDA-approved selective MC1R agonist used to increase eumelanin density in erythropoietic protoporphyria patients. Off-label cosmetic tanning use is widespread internationally.

Gonadorelin

FDA ✓

FDA-approved (Factrel) historically for diagnostic GnRH stimulation; off-label use in TRT to preserve testicular function

Synthetic GnRH used clinically to stimulate LH/FSH release. In testosterone replacement therapy, used pulsatile to preserve testicular size and fertility instead of hCG.

GHRH (1–44)

FDA ✓

FDA-approved (Geref) historically as diagnostic GH stimulant; current US availability limited

The full 44-amino-acid GHRH sequence. The natural pituitary stimulus for GH release. Largely supplanted in clinical use by sermorelin/tesamorelin but remains a research and diagnostic tool.

Why PeptideDive?

Evidence-Graded

Every peptide profile includes an evidence grade from A+ (large RCTs) to C (preliminary/animal data only). Know exactly how strong the science is.

Zero Vendor Ties

No affiliate links. No sponsored rankings. No vendor partnerships. Our only incentive is accurate, useful information.

Regulatory Tracking

Live FDA Category 1/2 status for every peptide. Know what's legal to compound, what's banned, and what's changing in real time.